Join
Live feed
·
INSIDERFilingvia Quantisnow
Compass Therapeutics Inc. logo

SEC Form 4: Schuetz Thomas J. bought $83,800 worth of shares (20,000 units at $4.19), increasing direct ownership by 0.37% to 5,451,873 units

ByQuantisnow·Wall Street's wire, on your screen.
CMPX· Compass Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMPX (Compass Therapeutics Inc.) and more on Quantisnow.